Heated Lidocaine Patch Compared to Subacromial Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome, A Pilot

NCT01544283 Phase 2 UNKNOWN

Objective: This purpose of this pilot study is to explore the potential usefulness of Synera for the treatment of pain associated with shoulder impingement syndrome.

Details

Lead sponsor	Injury Care Medical Center
Phase	Phase 2
Status	UNKNOWN
Enrolment	60
Start date	2012-03
Completion	2014-03

Conditions

• Shoulder Pain

Interventions

• Synera® (lidocaine 70 mg and tetracaine 70 mg) topical patch
• Triamcinolone Acetonide

Primary outcomes

• Pain Intensity — 6 weeks
  Average pain and worst pain over past 24 hours will be measured.

Countries

United States